CAPRICOR THERAPEUTICS, INC. Shareholders' Equity
CAPRICOR THERAPEUTICS, INC. (CAPR) had Shareholders' Equity of $246.22 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-14
- 2026-06-30: Stockholders' Equity Attributable to Parent $246.22M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $278.70M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $305.79M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $83.87M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $246.22M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $278.70M 10-Q · filed 2026-08-14 | |
| 2025-12-31 | $305.79M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $83.87M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $104.98M 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $127.65M 10-Q · filed 2026-08-14 | |
| 2024-12-31 | $145.46M 10-Q · filed 2026-08-14 | |
| 2024-09-30 | $68.26M 10-Q · filed 2025-11-10 | |
| 2024-06-30 | $11.50M 10-Q · filed 2025-11-10 | |
| 2024-03-31 | $18.43M 10-Q · filed 2025-11-10 | |
| 2023-12-31 | $22.60M 10-K · filed 2026-03-17 | |
| 2023-09-30 | -$1.79M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $2.73M 10-Q · filed 2024-11-14 | |
| 2023-03-31 | $6.21M 10-Q · filed 2024-11-14 | |
| 2022-12-31 | $11.79M 10-K · filed 2025-03-26 | |
| 2022-09-30 | $15.43M 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $18.73M 10-Q · filed 2023-11-14 | |
| 2022-03-31 | $24.64M 10-Q · filed 2023-11-14 | |
| 2021-12-31 | $31.37M 10-K · filed 2024-03-11 | |
| 2021-09-30 | $36.74M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $33.38M 10-Q · filed 2022-11-10 | |
| 2021-03-31 | $36.38M 10-Q · filed 2022-11-10 | |
| 2020-12-31 | $28.20M 10-K · filed 2023-03-17 | |
| 2020-09-30 | $30.41M 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $31.65M 10-Q · filed 2021-11-12 | |
| 2020-03-31 | $9.59M 10-Q · filed 2021-11-12 | |
| 2019-12-31 | $6.84M 10-K · filed 2022-03-11 | |
| 2019-09-30 | $3.57M 10-Q · filed 2020-11-13 | |
| 2019-06-30 | $2.36M 10-Q · filed 2020-11-13 | |
| 2019-03-31 | $3.74M 10-Q · filed 2020-11-13 | |
| 2018-12-31 | $4.62M 10-K · filed 2021-03-15 | |
| 2018-09-30 | $6.98M 10-Q · filed 2019-11-08 | |
| 2018-06-30 | $9.63M 10-Q · filed 2019-11-08 | |
| 2018-03-31 | $10.53M 10-Q · filed 2019-11-08 | |
| 2017-12-31 | $11.23M 10-K · filed 2020-03-27 | |
| 2017-09-30 | -$4.27M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | -$6.59M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | -$7.19M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | -$4.00M 10-K · filed 2019-03-29 | |
| 2016-09-30 | $49.13K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | -$5.12M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | -$1.08M 10-Q · filed 2016-05-13 | |
| 2015-12-31 | -$1.03M 10-K · filed 2018-03-22 | |
| 2015-09-30 | $1.93M 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $4.56M 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $7.32M 10-Q · filed 2015-05-13 | |
| 2014-12-31 | -$6.25M 10-K · filed 2017-03-16 | |
| 2014-09-30 | -$4.47M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | -$3.08M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | -$1.66M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | -$534.88K 10-K · filed 2016-03-30 | |
| 2013-09-30 | -$1.57M 10-Q · filed 2013-11-14 | |
| 2013-06-30 | -$1.23M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | -$642.66K 10-Q · filed 2013-06-21 | |
| 2012-12-31 | $4.89M 10-K · filed 2015-03-16 | -$167.31K 10-K · filed 2013-06-21 |
| 2012-09-30 | $27.23K 10-Q · filed 2013-06-21 | |
| 2012-06-30 | $542.25K 10-Q/A · filed 2012-09-10 | |
| 2012-03-31 | $230.66K 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $1.66M 10-Q · filed 2014-05-15 | $830.72K 10-K · filed 2012-04-02 |
| 2011-09-30 | $2.37M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $3.27M 10-Q · filed 2011-08-15 | |
| 2010-12-31 | $1.79M 10-Q · filed 2014-05-15 | $2.60M 10-Q · filed 2011-08-15 |
| 2009-12-31 | $911.77K 10-Q · filed 2014-05-15 | $2.98M 10-Q · filed 2011-08-15 |
| 2008-12-31 | $252.55K 10-Q · filed 2014-05-15 | $5.10M 10-Q · filed 2011-08-15 |
| 2007-12-31 | $863.17K 10-Q · filed 2014-05-15 | $15.20M 10-Q · filed 2011-08-15 |
| 2006-12-31 | $1.84M 10-Q · filed 2014-05-15 | -$2.58M 10-Q · filed 2011-08-15 |
| 2005-12-31 | $0.00 10-Q · filed 2014-05-15 | -$5.04K 10-Q · filed 2011-08-15 |
| 2005-07-04 | $0.00 10-Q · filed 2014-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |